We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Techniques Compared for Diagnosis of Rickettsioses

By LabMedica International staff writers
Posted on 19 Mar 2012
The diagnosis and isolation of Rickettsia species from skin biopsies may be replaced by a real time polymerase chain reaction (rt-PCR). More...


Diagnosis of Rickettsia infection would benefit by use of the more rapid and sensitive method of quantitative rt-PCR than the time-intensive and less sensitive method of culturing Rickettsia species from skin biopsies.

Scientists at the University of the Mediterranean (Marseille, France) analyzed punch biopsies or scalpel incisions of eschars collected from patients with suspected rickettsial infections between January 2007 and January 2010. Patients were classified as definitely having rickettsiosis if there was direct evidence of infection with a Rickettsia species using culture or molecular assays or if serology was positive. Rickettsial diseases are zoonoses caused by obligate intracellular bacteria.

Total genomic DNA was extracted from samples using a QIAamp tissue kit (Qiagen, Hilden, Germany). Samples were screened for the presence of Rickettsia species using a previously developed rt-PCR assay targeting a 109 base pairs (bp) fragment of a hypothetical protein. Quantification of Rickettsia species were performed using serial ten-fold dilutions of R. africae, R. slovaca, R. raoultii, and R. helvetica. Bacteria were detected by indirect immunofluorescence using human serum and antiserum. All sera were tested by immunofluorescence (IF) for spotted fever group (SFG) rickettsial antigens. Samples were cultured in human embryonic lung (HEL) fibroblasts using the centrifugation-shell vial technique.

Rickettsia species infection was diagnosed in 47/145 (32%) skin biopsies from patients with suspected rickettsiosis. By rt-PCR a positive result was obtained for 41 skin biopsies (28.2%). Rickettsia africae was the most common detected species, followed by R. conorii conorii, R. slovaca, R. sibirica mongolitimonae, and R. raoultii. Comparison of culture and rt-PCR to serology was done for the 26 patients with suspected rickettsiosis with a skin biopsy that also had an acute serum and a convalescent-phase serum sample. The rt-PCR sensitivity was 82% as compared to serology whereas culture sensitivity was 29.4% as compared to serology.

The author concluded that for the diagnosis of Rickettsia infection the use of molecular and culture diagnostic tools, decreases the time of diagnosis and increases the sensitivity. However, a negative result using molecular assays does not exclude the diagnosis of Rickettsia infection. To increase the sensitivity of culture, skin biopsies should be sampled before treatment early in the course of the disease and should be inoculated as soon as possible. The study was published on March 6, 2012, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

University of the Mediterranean
Qiagen




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.